Increasing GP referrals: Jump or infectious push?

British Journal of Health Care Management

Volumn 18, Issue 9, 2012, Pages 487-496

  Jones, Rod ^a  

^a Healthcare Analysis and Forecasting   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866239354     PISSN: 13580574     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjhc.2012.18.9.487     Document Type: Article

References (47)

1. Ballanger F, Bressollette C, Volteau C et al (2009) Cytomegalovirus: its potential role in the development of cutaneous T-cell lymphoma. Exper Dermatol 18(6): 574-6
2. Blunt I, Bardsley M, Dixon J (2010) Trends in Emergency Admission in England 2004-2009: Is Greater Efficiency Breeding Inefficiency? The Nuffield Trust, London
3. Cannon M, Schmid D, Hyde T (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20(4): 202-213
4. Crighton E, Elliott S, Moineddin R, Kanaroglou P, Upshur R (2007) An exploratory spatial analysis of pneumonia and influenza hospitalizations in Ontario by age and gender. Epidemiol Infect 135(2): 253-61
5. Crighton E, Elliott S, Kanaroglou P, Moineddin R, Upshur R (2008) Spatio-temporal analysis of pneumonia and influenza hospitalizations in Ontario, Canada. Geospat Health 2(2): 191-202
6. Docke W, Kiessling C, Worm M et al (2003) Subclinical activation of latent cytomegalovirus infection and anti-CMV immune response in patients with atopic dermatitis. Br J Dermatoil 148(5): 954-63
7. Eizuru Y, Minamishima Y, Hirose M et al (1990) Isolation of multiple cytomegalovirus strains from a patient with T cell leukaemia. Intervirology 31(6): 355-8
8. Eubank S, Guclu H, Kumar A, Marathe M et al (2004) Modelling disease outbreaks in realistic urban social networks. Nature 429(6988): 180-4
9. Farnsworth M, Ward M (2009) Spatio-temporal patterns of transboundary disease spread: examples using avian influenza H5N1 outbreaks. Vet Res 40(3): 20
10. Fink W, Lipatov V, Konitzer M (2009) Diagnoses by General Practitioners: accuracy and reliability. International Journal of Forecasting 25(4): 784-3
11. Hafez S, Shehata I, Abdel Aziz G, Kamal M (2005) Active cytomegalovirus infection in patients with atopic dermatitis. Egypt J Immunol 12(2):1-12
12. Hyams K (1998) Developing case definitions for symptombased conditions: the problem of specificity. Epidemiol Rev 20(2): 148-56
13. Hyde T, Schmid D, Cannon M (2010) Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 20(5): 311-26
14. Jones R (1996) Emergency admissions in the United Kingdom: Trend Upward or Fundamental Shift. Healthcare Analysis & Forecasting, Camberley
15. Jones R (2007) Equilibrium. A Report on the Balance Between Providers and Commissioners Over Use of the NHS Data Standards in Admitted Patient Care. Healthcare Analysis & Forecasting, Camberley
16. Jones R (2009a) Trends in emergency admissions. BJHCM 15(4): 188-96
17. Jones R (2009b) Emergency admissions and financial risk. BJHCM 15(7): 344-50
18. Jones R (2010a) Myths of ideal hospital size. Med J Aust 193(5): 298-300
19. Jones R (2010b) The case for recurring outbreaks of a new type of infectious disease across all parts of the United Kingdom. Med Hypotheses 75(5): 452-7
20. Jones R (2010c) Emergency preparedness. BJHCM 16(2): 94-5
21. Jones R (2010d) Nature of health care costs and financial risk in commissioning. BJHCM 16(9): 424-30
22. Jones R (2010e) Forecasting emergency department attendances. BJHCM 16(10): 495-6
23. Jones R (2010f) Trends in programme budget expenditure. BJHCM 16(11): 518-26
24. Jones R (2010g) Emergency assessment tariff: lessons learned. BJHCM 16(12): 574-83
25. Jones R (2011a) Infectious outbreaks and the capitation formula. BJHCM 17(1): 36-8
26. Jones R (2011b) Hospital bed occupancy demystified and why hospitals of different size and complexity must operate at different average occupancy. BJHCM 17(6): 242-8
27. Jones R (2011c) A&E performance and inpatient bed occupancy. BJHCM 17(6): 256-7
28. Jones R (2011d) Volatility in bed occupancy for emergency admissions. BJHCM 17(9): 424-30
29. Jones R (2012a) Time to re-evaluate financial risk in GP commissioning. BJHCM 18(1): 39-48
30. Jones R (2012b) Ambulance call-outs and disruptive technology. BJHCM 18(2): 112-3
31. Jones R (2012c) Are there cycles in outpatient costs? BJHCM 18(5): 276-7
32. Jones R (2012d) Volatile inpatient costs: implications to CCG financial stability. BJHCM 18(5): 251-8
33. Jones R (2012e) Financial risk in commissioning: cancer costs. BJHCM 18(6): 315-24
34. Jones R (2012f) End of life and financial risk in GP commissioning. BJHCM 18(7): 374-81
35. Jones R (2012g) Age and financial risk in healthcare costs. BJHCM 18(7): 388-9
36. Jones R (2012h) Changes in A&E attendance by age. BJHCM 18(9): 502-3
37. Jones R (2012i) Could cytomegalovirus be causing widespread outbreaks of chronic poor health. In: M Shoja, ed. Hypotheses in Clinical Medicine. Nova Science Publishers Inc, New York
38. Lee J (1989) Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol 92(1): 96-100
39. Ozcan D, Sechin D, Bilezikci B, et al (2010) The role of human herpesvirus-6, Epstein-Barr virus and cytomegalovirus infections in the eitopathogenesis of different types of cutaneous drug reactions. Int JDermatol 49(11): 1250-4
40. Posnett D, Yarilin D (2005) Amplification of autoimmune disease by infection. Arthritis Research & Therapy 7(2): 74-84
41. Seishima M, Oyama Z, Yamamura M (2001) Erythema multiforme associated with cytomegalovirus infection in nonimmunosuppressed patients. Dermatology 203: 299-302
42. Seishima M, Yamanaka S, Fujisawa T et al (2006) Reactivation of human herpesvirus family members other than HHV-6 in drug induced hypersensitivity syndrome. Br J Dermatol 155(2): 344-9
43. Sharma R, Stano M, Gehring R (2008) Short-term fluctuations in hospital demand: implications for admission, discharge and discriminatory behaviour. Rand J Econ 39(2): 586-606
44. Varani S, Landini M (2011) Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2(1):6
45. Wanner M, Pol-Rodriguez M, Hinds G et al (2007) Persistent erythema multiforme and CMV infection. J Drugs Dermatol 6(3): 333-6
46. Weigand D, Burgdorf W, Tarpay M (1980) Vasculitis in cytomegalovirus infection. Arch Dermatol 116(10) 1174-6
47. Weitz M, Kiessling C, Friedrich M et al (2011) Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis. Exper Dermatol 20(7): 561-7